Hillhouse Capital Management, Ltd. - Net Worth and Insider Trading

Hillhouse Capital Management, Ltd. Net Worth

The estimated net worth of Hillhouse Capital Management, Ltd. is at least $1.6 Billion dollars as of 2025-06-07. Hillhouse Capital Management, Ltd. is the 2102 Investment manager of Luye Pharma Group Ltd and owns about 552,324,108 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $1.6 Billion. Details can be seen in Hillhouse Capital Management, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hillhouse Capital Management, Ltd. has not made any transactions after 2021-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Hillhouse Capital Management, Ltd.

To

Hillhouse Capital Management, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hillhouse Capital Management, Ltd. owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .

Click here to see the complete history of Hillhouse Capital Management, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Hillhouse Capital Management, Ltd.

Ticker Company Transaction Date Type of Owner
HKSE:02186 Luye Pharma Group Ltd 2021-02-08 2102 Investment manager

Hillhouse Capital Management, Ltd. Latest Holdings Summary

Hillhouse Capital Management, Ltd. currently owns a total of 1 stock. Hillhouse Capital Management, Ltd. owns 552,324,108 shares of Luye Pharma Group Ltd (HKSE:02186) as of February 8, 2021, with a value of $1.6 Billion.

Latest Holdings of Hillhouse Capital Management, Ltd.

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:02186 Luye Pharma Group Ltd 2021-02-08 552,324,108 2.94 1,623,832,878

Holding Weightings of Hillhouse Capital Management, Ltd.


Hillhouse Capital Management, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Hillhouse Capital Management, Ltd. has made a total of 1 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on February 8, 2021, which brought Hillhouse Capital Management, Ltd. around $0.

Insider Trading History of Hillhouse Capital Management, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hillhouse Capital Management, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hillhouse Capital Management, Ltd. Ownership Network

Ownership Network List of Hillhouse Capital Management, Ltd.

No Data

Ownership Network Relation of Hillhouse Capital Management, Ltd.

Insider Network Chart


Hillhouse Capital Management, Ltd. Owned Company Details

What does Luye Pharma Group Ltd do?

Who are the key executives at Luye Pharma Group Ltd?

Hillhouse Capital Management, Ltd. is the 2102 Investment manager of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2301 Trustee Liu Dianbo , and 2201 Interest of corporation controlled by you Luye Life Sciences Group Ltd .

Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary

Over the past 18 months, Hillhouse Capital Management, Ltd. made no insider transaction in Luye Pharma Group Ltd (HKSE:02186). Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net purchase of 3,569,500 shares made by UBS Group AG , a net purchase of 6,000,000 shares made by Shorea Lbg , and a net purchase of 6,000,000 shares made by Ginkgo (ptc) Limited .

In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 14,000,000 shares, with a net purchase of 14,000,000 shares. During the past 18 months, 0 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 49,569,500 shares were bought by its insiders, resulting in a net purchase of 49,569,500 shares.

Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Luye Pharma Group Ltd Insider Transactions

No Available Data

Hillhouse Capital Management, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Hillhouse Capital Management, Ltd.. Currently GuruFocus does not have mailing address information for Hillhouse Capital Management, Ltd..